HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Color additive petition

This article was originally published in The Rose Sheet

Executive Summary

Color additive petition: Melvindale, MI-based Ebonex files a petition with FDA requesting that bone black be approved as a color additive for use in cosmetics, including cosmetics used in the eye area, according to a Sept. 1 Federal Register notice. In the environmental assessment portion of the firm's submission, Ebonex said that the pigment, which is made by carbonizing bones, has been determined by NTP-IARC to be non-carcinogenic. In addition, the submission states, "FDA regards bone black as GRAS" (generally recognized as safe) for contact with food. According to Ebonex, the pigment is currently used in various products including paints, plastics and crayons for children. The firm describes bone black as a "niche black," explaining that the pigment, which has low oil absorption, provides a flat, non-glossy, matte color...
Advertisement

Related Content

FDA OKs Use Of “Bone Black” In Cosmetics, Gives One Month For Objections
FDA OKs Use Of “Bone Black” In Cosmetics, Gives One Month For Objections
Advertisement
UsernamePublicRestriction

Register

RS001998

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel